Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Drug Market 2018, Forecast to 2023

Publisher Name :
Date: 10-Jun-2018
No. of pages: 132

Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine.

Scope of the Report:

This report focuses on the Biosimilar Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

As healthcare costs continue to rise, biosimilars offer new therapeutic options with the potential for cost savings to the healthcare system. With anticipated savings, biosimilars bring hope that there will be expanded access for patients to not only these known therapies, but also to new innovative medicines. At Amgen, serving patients is at the core of what we do and it is why we're using our more than 35 years of biologics experience to develop high-quality biosimilars.

First, in pharmerging markets, both governments and patients struggle to pay for biosimilars, which encouraged the demand of biosimilars, therefore in the future the biosimilars will grow around 20%.

Second, generally, biosimilars industry is still in their infancy in China. It is commonly believed that the next 10 to 15 years is the golden period of the development of biosimilars.

Third, for the biosimilars industry, technical barriers will be much smaller, in the next few years, there will be more and more enterprises going into biosimilars industry.

Forth, most of biosimilars manufacturer are concentrated in US, Germany, UK and other developed countries.

At last, through the research we tend to believe that the biosimilars, now is a chance for newcomers and they will greatly change the industry.

The worldwide market for Biosimilar Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- - Amgen

- - Eli Lilly

- - Novartis

- - CP Guojian Pharma

- - Biotech Pharma

Market Segment by Regions, regional analysis covers

- - North America (United States, Canada and Mexico)

- - Europe (Germany, France, UK, Russia and Italy)

- - Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- - South America (Brazil, Argentina, Colombia etc.)

- - Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- - Injection

- - Tablets

- - Other Types

Market Segment by Applications, can be divided into

- - Ankylosing Spondylitis

- - Tumor

- - Rheumatoid Arthrtis

- - Cardiovascular

- - Other Application

There are 15 Chapters to deeply display the global Biosimilar Drug market.

Chapter 1, to describe Biosimilar Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biosimilar Drug, with sales, revenue, and price of Biosimilar Drug, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar Drug, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Biosimilar Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Biosimilar Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biosimilar Drug Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Biosimilar Drug Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Tablets
1.2.3 Other Types
1.3 Market Analysis by Applications
1.3.1 Ankylosing Spondylitis
1.3.2 Tumor
1.3.3 Rheumatoid Arthrtis
1.3.4 Cardiovascular
1.3.5 Other Application
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.1.1 Amgen Description
2.1.1.2 Amgen Headquarter, Main Business and Finance Overview
2.1.2 Amgen Biosimilar Drug Product Introduction
2.1.2.1 Biosimilar Drug Production Bases, Sales Regions and Major Competitors
2.1.2.2 Biosimilar Drug Product Information
2.1.3 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Amgen Biosimilar Drug Market Share in 2017
2.2 Eli Lilly
2.2.1 Business Overview
2.2.1.1 Eli Lilly Description
2.2.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
2.2.2 Eli Lilly Biosimilar Drug Product Introduction
2.2.2.1 Biosimilar Drug Production Bases, Sales Regions and Major Competitors
2.2.2.2 Biosimilar Drug Product Information
2.2.3 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Eli Lilly Biosimilar Drug Market Share in 2017
2.3 Novartis
2.3.1 Business Overview
2.3.1.1 Novartis Description
2.3.1.2 Novartis Headquarter, Main Business and Finance Overview
2.3.2 Novartis Biosimilar Drug Product Introduction
2.3.2.1 Biosimilar Drug Production Bases, Sales Regions and Major Competitors
2.3.2.2 Biosimilar Drug Product Information
2.3.3 Novartis Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Novartis Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Novartis Biosimilar Drug Market Share in 2017
2.4 CP Guojian Pharma
2.4.1 Business Overview
2.4.1.1 CP Guojian Pharma Description
2.4.1.2 CP Guojian Pharma Headquarter, Main Business and Finance Overview
2.4.2 CP Guojian Pharma Biosimilar Drug Product Introduction
2.4.2.1 Biosimilar Drug Production Bases, Sales Regions and Major Competitors
2.4.2.2 Biosimilar Drug Product Information
2.4.3 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global CP Guojian Pharma Biosimilar Drug Market Share in 2017
2.5 Biotech Pharma
2.5.1 Business Overview
2.5.1.1 Biotech Pharma Description
2.5.1.2 Biotech Pharma Headquarter, Main Business and Finance Overview
2.5.2 Biotech Pharma Biosimilar Drug Product Introduction
2.5.2.1 Biosimilar Drug Production Bases, Sales Regions and Major Competitors
2.5.2.2 Biosimilar Drug Product Information
2.5.3 Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Biotech Pharma Biosimilar Drug Market Share in 2017
3 Global Biosimilar Drug Market Competition, by Manufacturer
3.1 Global Biosimilar Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Biosimilar Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Biosimilar Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Biosimilar Drug Manufacturer Market Share in 2017
3.4.2 Top 5 Biosimilar Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Biosimilar Drug Market Analysis by Regions
4.1 Global Biosimilar Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Biosimilar Drug Sales by Regions (2013-2018)
4.1.2 Global Biosimilar Drug Revenue by Regions (2013-2018)
4.2 North America Biosimilar Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilar Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilar Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilar Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilar Drug Sales, Revenue and Growth Rate (2013-2018)
5 North America Biosimilar Drug by Countries, Type, Application and Manufacturers
5.1 North America Biosimilar Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Biosimilar Drug Sales by Countries (2013-2018)
5.1.2 North America Biosimilar Drug Revenue by Countries (2013-2018)
5.1.3 United States Biosimilar Drug Sales and Growth Rate (2013-2018)
5.1.4 Canada Biosimilar Drug Sales and Growth Rate (2013-2018)
5.1.5 Mexico Biosimilar Drug Sales and Growth Rate (2013-2018)
5.2 North America Biosimilar Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Biosimilar Drug Sales by Manufacturers (2016-2017)
5.2.2 North America Biosimilar Drug Revenue by Manufacturers (2016-2017)
5.3 North America Biosimilar Drug Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Biosimilar Drug Sales and Sales Share by Type (2013-2018)
5.3.2 North America Biosimilar Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Biosimilar Drug Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Biosimilar Drug Sales and Sales Share by Application (2013-2018)
5.4.2 North America Biosimilar Drug Revenue and Revenue Share by Application (2013-2018)
6 Europe Biosimilar Drug by Countries, Type, Application and Manufacturers
6.1 Europe Biosimilar Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Biosimilar Drug Sales by Countries (2013-2018)
6.1.2 Europe Biosimilar Drug Revenue by Countries (2013-2018)
6.1.3 Germany Biosimilar Drug Sales and Growth Rate (2013-2018)
6.1.4 UK Biosimilar Drug Sales and Growth Rate (2013-2018)
6.1.5 France Biosimilar Drug Sales and Growth Rate (2013-2018)
6.1.6 Russia Biosimilar Drug Sales and Growth Rate (2013-2018)
6.1.7 Italy Biosimilar Drug Sales and Growth Rate (2013-2018)
6.2 Europe Biosimilar Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Biosimilar Drug Sales by Manufacturers (2016-2017)
6.2.2 Europe Biosimilar Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Biosimilar Drug Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Biosimilar Drug Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Biosimilar Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Biosimilar Drug Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Biosimilar Drug Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Biosimilar Drug Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Biosimilar Drug by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Biosimilar Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Biosimilar Drug Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Biosimilar Drug Revenue by Countries (2013-2018)
7.1.3 China Biosimilar Drug Sales and Growth Rate (2013-2018)
7.1.4 Japan Biosimilar Drug Sales and Growth Rate (2013-2018)
7.1.5 Korea Biosimilar Drug Sales and Growth Rate (2013-2018)
7.1.6 India Biosimilar Drug Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Biosimilar Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Biosimilar Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Biosimilar Drug Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Biosimilar Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Biosimilar Drug Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Biosimilar Drug Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Biosimilar Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Biosimilar Drug Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Biosimilar Drug Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Biosimilar Drug Revenue and Revenue Share by Application (2013-2018)
8 South America Biosimilar Drug by Countries, Type, Application and Manufacturers
8.1 South America Biosimilar Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Biosimilar Drug Sales by Countries (2013-2018)
8.1.2 South America Biosimilar Drug Revenue by Countries (2013-2018)
8.1.3 Brazil Biosimilar Drug Sales and Growth Rate (2013-2018)
8.1.4 Argentina Biosimilar Drug Sales and Growth Rate (2013-2018)
8.1.5 Colombia Biosimilar Drug Sales and Growth Rate (2013-2018)
8.2 South America Biosimilar Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Biosimilar Drug Sales by Manufacturers (2016-2017)
8.2.2 South America Biosimilar Drug Revenue by Manufacturers (2016-2017)
8.3 South America Biosimilar Drug Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Biosimilar Drug Sales and Sales Share by Type (2013-2018)
8.3.2 South America Biosimilar Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Biosimilar Drug Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Biosimilar Drug Sales and Sales Share by Application (2013-2018)
8.4.2 South America Biosimilar Drug Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Biosimilar Drug by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Biosimilar Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Biosimilar Drug Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Biosimilar Drug Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Biosimilar Drug Sales and Growth Rate (2013-2018)
9.1.4 UAE Biosimilar Drug Sales and Growth Rate (2013-2018)
9.1.5 Egypt Biosimilar Drug Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Biosimilar Drug Sales and Growth Rate (2013-2018)
9.1.7 South Africa Biosimilar Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Biosimilar Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Biosimilar Drug Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Biosimilar Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Biosimilar Drug Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Biosimilar Drug Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Biosimilar Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Biosimilar Drug Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Biosimilar Drug Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Biosimilar Drug Revenue and Revenue Share by Application (2013-2018)
10 Global Biosimilar Drug Market Segment by Type
10.1 Global Biosimilar Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Biosimilar Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Biosimilar Drug Revenue and Market Share by Type (2013-2018)
10.2 Injection Sales Growth and Price
10.2.1 Global Injection Sales Growth (2013-2018)
10.2.2 Global Injection Price (2013-2018)
10.3 Tablets Sales Growth and Price
10.3.1 Global Tablets Sales Growth (2013-2018)
10.3.2 Global Tablets Price (2013-2018)
10.4 Other Types Sales Growth and Price
10.4.1 Global Other Types Sales Growth (2013-2018)
10.4.2 Global Other Types Price (2013-2018)
11 Global Biosimilar Drug Market Segment by Application
11.1 Global Biosimilar Drug Sales Market Share by Application (2013-2018)
11.2 Ankylosing Spondylitis Sales Growth (2013-2018)
11.3 Tumor Sales Growth (2013-2018)
11.4 Rheumatoid Arthrtis Sales Growth (2013-2018)
11.5 Cardiovascular Sales Growth (2013-2018)
11.6 Other Application Sales Growth (2013-2018)
12 Biosimilar Drug Market Forecast (2018-2023)
12.1 Global Biosimilar Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Biosimilar Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Biosimilar Drug Market Forecast (2018-2023)
12.2.2 Europe Biosimilar Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Biosimilar Drug Market Forecast (2018-2023)
12.2.4 South America Biosimilar Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Biosimilar Drug Market Forecast (2018-2023)
12.3 Biosimilar Drug Market Forecast by Type (2018-2023)
12.3.1 Global Biosimilar Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Biosimilar Drug Market Share Forecast by Type (2018-2023)
12.4 Biosimilar Drug Market Forecast by Application (2018-2023)
12.4.1 Global Biosimilar Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Biosimilar Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source


List of Tables and Figures

Figure Biosimilar Drug Picture
Table Product Specifications of Biosimilar Drug
Figure Global Biosimilar Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Biosimilar Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Biosimilar Drug by Types in 2017
Figure Injection Picture
Table Major Manufacturers of Injection
Figure Tablets Picture
Table Major Manufacturers of Tablets
Figure Other Types Picture
Table Major Manufacturers of Other Types
Figure Biosimilar Drug Sales Market Share by Applications in 2017
Figure Ankylosing Spondylitis Picture
Figure Tumor Picture
Figure Rheumatoid Arthrtis Picture
Figure Cardiovascular Picture
Figure Other Application Picture
Figure United States Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biosimilar Drug Revenue (Value) and Growth Rate (2013-2023)
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Biosimilar Drug Production Bases, Sales Regions and Major Competitors
Table Amgen Biosimilar Drug Product
Table Amgen Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Biosimilar Drug Sales Market Share in 2017
Figure Global Amgen Biosimilar Drug Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Biosimilar Drug Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Biosimilar Drug Product
Table Eli Lilly Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Biosimilar Drug Sales Market Share in 2017
Figure Global Eli Lilly Biosimilar Drug Revenue Market Share in 2017
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Biosimilar Drug Production Bases, Sales Regions and Major Competitors
Table Novartis Biosimilar Drug Product
Table Novartis Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Biosimilar Drug Sales Market Share in 2017
Figure Global Novartis Biosimilar Drug Revenue Market Share in 2017
Table CP Guojian Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table CP Guojian Pharma Biosimilar Drug Production Bases, Sales Regions and Major Competitors
Table CP Guojian Pharma Biosimilar Drug Product
Table CP Guojian Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global CP Guojian Pharma Biosimilar Drug Sales Market Share in 2017
Figure Global CP Guojian Pharma Biosimilar Drug Revenue Market Share in 2017
Table Biotech Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Biotech Pharma Biosimilar Drug Production Bases, Sales Regions and Major Competitors
Table Biotech Pharma Biosimilar Drug Product
Table Biotech Pharma Biosimilar Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Biotech Pharma Biosimilar Drug Sales Market Share in 2017
Figure Global Biotech Pharma Biosimilar Drug Revenue Market Share in 2017
Table Global Biosimilar Drug Sales by Manufacturer (2016-2017)
Figure Global Biosimilar Drug Sales Market Share by Manufacturer in 2016
Figure Global Biosimilar Drug Sales Market Share by Manufacturer in 2017
Table Global Biosimilar Drug Revenue by Manufacturer (2016-2017)
Figure Global Biosimilar Drug Revenue Market Share by Manufacturer in 2016
Figure Global Biosimilar Drug Revenue Market Share by Manufacturer in 2017
Table Global Biosimilar Drug Price by Manufacturer (2016-2017)
Figure Top 3 Biosimilar Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Biosimilar Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Global Biosimilar Drug Revenue and Growth Rate (2013-2018)
Table Global Biosimilar Drug Sales by Regions (2013-2018)
Table Global Biosimilar Drug Sales Market Share by Regions (2013-2018)
Table Global Biosimilar Drug Revenue by Regions (2013-2018)
Figure Global Biosimilar Drug Revenue Market Share by Regions in 2013
Figure Global Biosimilar Drug Revenue Market Share by Regions in 2017
Figure North America Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure North America Biosimilar Drug Revenue and Growth Rate (2013-2018)
Figure Europe Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biosimilar Drug Revenue and Growth Rate (2013-2018)
Figure South America Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure South America Biosimilar Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biosimilar Drug Revenue and Growth Rate (2013-2018)
Figure North America Biosimilar Drug Revenue and Growth Rate (2013-2018)
Table North America Biosimilar Drug Sales by Countries (2013-2018)
Table North America Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure North America Biosimilar Drug Sales Market Share by Countries in 2013
Figure North America Biosimilar Drug Sales Market Share by Countries in 2017
Table North America Biosimilar Drug Revenue by Countries (2013-2018)
Table North America Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure North America Biosimilar Drug Revenue Market Share by Countries in 2013
Figure North America Biosimilar Drug Revenue Market Share by Countries in 2017
Figure United States Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Canada Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Mexico Biosimilar Drug Sales and Growth Rate (2013-2018)
Table North America Biosimilar Drug Sales by Manufacturer (2016-2017)
Figure North America Biosimilar Drug Sales Market Share by Manufacturer in 2016
Figure North America Biosimilar Drug Sales Market Share by Manufacturer in 2017
Table North America Biosimilar Drug Revenue by Manufacturer (2016-2017)
Figure North America Biosimilar Drug Revenue Market Share by Manufacturer in 2016
Figure North America Biosimilar Drug Revenue Market Share by Manufacturer in 2017
Table North America Biosimilar Drug Sales by Type (2013-2018)
Table North America Biosimilar Drug Sales Share by Type (2013-2018)
Table North America Biosimilar Drug Revenue by Type (2013-2018)
Table North America Biosimilar Drug Revenue Share by Type (2013-2018)
Table North America Biosimilar Drug Sales by Application (2013-2018)
Table North America Biosimilar Drug Sales Share by Application (2013-2018)
Table North America Biosimilar Drug Revenue by Application (2013-2018)
Table North America Biosimilar Drug Revenue Share by Application (2013-2018)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2013-2018)
Table Europe Biosimilar Drug Sales by Countries (2013-2018)
Table Europe Biosimilar Drug Sales Market Share by Countries (2013-2018)
Table Europe Biosimilar Drug Revenue by Countries (2013-2018)
Figure Europe Biosimilar Drug Revenue Market Share by Countries in 2016
Figure Europe Biosimilar Drug Revenue Market Share by Countries in 2017
Figure Germany Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure UK Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure France Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Russia Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Italy Biosimilar Drug Sales and Growth Rate (2013-2018)
Table Europe Biosimilar Drug Sales by Manufacturer (2016-2017)
Figure Europe Biosimilar Drug Sales Market Share by Manufacturer in 2016
Figure Europe Biosimilar Drug Sales Market Share by Manufacturer in 2017
Table Europe Biosimilar Drug Revenue by Manufacturer (2016-2017)
Figure Europe Biosimilar Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Biosimilar Drug Revenue Market Share by Manufacturer in 2017
Table Europe Biosimilar Drug Sales by Type (2013-2018)
Table Europe Biosimilar Drug Sales Share by Type (2013-2018)
Table Europe Biosimilar Drug Revenue by Type (2013-2018)
Table Europe Biosimilar Drug Revenue Share by Type (2013-2018)
Table Europe Biosimilar Drug Sales by Application (2013-2018)
Table Europe Biosimilar Drug Sales Share by Application (2013-2018)
Table Europe Biosimilar Drug Revenue by Application (2013-2018)
Table Europe Biosimilar Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Biosimilar Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Biosimilar Drug Sales by Countries (2013-2018)
Table Asia-Pacific Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Biosimilar Drug Sales Market Share by Countries 2017
Table Asia-Pacific Biosimilar Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Biosimilar Drug Revenue Market Share by Countries 2017
Figure China Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Japan Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Korea Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure India Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Biosimilar Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Biosimilar Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Biosimilar Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Biosimilar Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Biosimilar Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Biosimilar Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Biosimilar Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Biosimilar Drug Sales by Type (2013-2018)
Table Asia-Pacific Biosimilar Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Biosimilar Drug Revenue by Type (2013-2018)
Table Asia-Pacific Biosimilar Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Biosimilar Drug Sales by Application (2013-2018)
Table Asia-Pacific Biosimilar Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Biosimilar Drug Revenue by Application (2013-2018)
Table Asia-Pacific Biosimilar Drug Revenue Share by Application (2013-2018)
Figure South America Biosimilar Drug Revenue and Growth Rate (2013-2018)
Table South America Biosimilar Drug Sales by Countries (2013-2018)
Table South America Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure South America Biosimilar Drug Sales Market Share by Countries in 2017
Table South America Biosimilar Drug Revenue by Countries (2013-2018)
Table South America Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure South America Biosimilar Drug Revenue Market Share by Countries in 2017
Figure Brazil Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Argentina Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Colombia Biosimilar Drug Sales and Growth Rate (2013-2018)
Table South America Biosimilar Drug Sales by Manufacturer (2016-2017)
Figure South America Biosimilar Drug Sales Market Share by Manufacturer in 2016
Figure South America Biosimilar Drug Sales Market Share by Manufacturer in 2017
Table South America Biosimilar Drug Revenue by Manufacturer (2016-2017)
Figure South America Biosimilar Drug Revenue Market Share by Manufacturer in 2016
Figure South America Biosimilar Drug Revenue Market Share by Manufacturer in 2017
Table South America Biosimilar Drug Sales by Type (2013-2018)
Table South America Biosimilar Drug Sales Share by Type (2013-2018)
Table South America Biosimilar Drug Revenue by Type (2013-2018)
Table South America Biosimilar Drug Revenue Share by Type (2013-2018)
Table South America Biosimilar Drug Sales by Application (2013-2018)
Table South America Biosimilar Drug Sales Share by Application (2013-2018)
Table South America Biosimilar Drug Revenue by Application (2013-2018)
Table South America Biosimilar Drug Revenue Share by Application (2013-2018)
Figure Middle East and Africa Biosimilar Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Biosimilar Drug Sales by Countries (2013-2018)
Table Middle East and Africa Biosimilar Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Biosimilar Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Biosimilar Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biosimilar Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Biosimilar Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure UAE Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Egypt Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Biosimilar Drug Sales and Growth Rate (2013-2018)
Figure South Africa Biosimilar Drug Sales and Growth Rate (2013-2018)
Table Middle East and Africa Biosimilar Drug Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Biosimilar Drug Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Biosimilar Drug Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Biosimilar Drug Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Biosimilar Drug Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Biosimilar Drug Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Biosimilar Drug Sales by Type (2013-2018)
Table Middle East and Africa Biosimilar Drug Sales Share by Type (2013-2018)
Table Middle East and Africa Biosimilar Drug Revenue by Type (2013-2018)
Table Middle East and Africa Biosimilar Drug Revenue Share by Type (2013-2018)
Table Middle East and Africa Biosimilar Drug Sales by Application (2013-2018)
Table Middle East and Africa Biosimilar Drug Sales Share by Application (2013-2018)
Table Middle East and Africa Biosimilar Drug Revenue by Application (2013-2018)
Table Middle East and Africa Biosimilar Drug Revenue Share by Application (2013-2018)
Table Global Biosimilar Drug Sales by Type (2013-2018)
Table Global Biosimilar Drug Sales Share by Type (2013-2018)
Table Global Biosimilar Drug Revenue by Type (2013-2018)
Table Global Biosimilar Drug Revenue Share by Type (2013-2018)
Figure Global Injection Sales Growth (2013-2018)
Figure Global Injection Price (2013-2018)
Figure Global Tablets Sales Growth (2013-2018)
Figure Global Tablets Price (2013-2018)
Figure Global Other Types Sales Growth (2013-2018)
Figure Global Other Types Price (2013-2018)
Table Global Biosimilar Drug Sales by Application (2013-2018)
Table Global Biosimilar Drug Sales Share by Application (2013-2018)
Figure Global Ankylosing Spondylitis Sales Growth (2013-2018)
Figure Global Tumor Sales Grow
  • Global Biosimilar Drug Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Jun-2018        Price: US 3480 Onwards        Pages: 133
    Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodys drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biosimilar Drug in global market, especial......
  • Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 09-Jun-2018        Price: US 3480 Onwards        Pages: 154
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, espe......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Biologics and Biosimilars Market 2018, Forecast to 2023
    Published: 09-Jun-2018        Price: US 4880 Onwards        Pages: 150
    A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine. Scope of the Report: This report focuses on the Biologics and Biosimilars in global market, espe......
  • Global and China Adalimumab Biosimilar Market Research by Company, Type & Application 2013-2025
    Published: 25-May-2018        Price: US 2000 Onwards        Pages: 78
    Summary Market Segment as follows: By Type - Tablet - Oral Solution By Application - Hospital Pharmacy - Retail Pharmacy - Online Pharmacy By Company - AET BioTech - Amgen - Boehringer Ingelheim - Coherus Biosciences - Fujifilm Kyowa Kirin Biologics - LG Life Sciences/Mochida Pharmaceutical - Momenta Pharmaceuticals - Oncobiologics - Pfize......
  • United States Biosimilar Monoclonal Antibodies Market Report 2018
    Published: 23-May-2018        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Biosimilar Monoclonal Antibodies market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share an......
  • Global Biosimilar Monoclonal Antibodies Market Research Report 2018
    Published: 18-May-2018        Price: US 2900 Onwards        Pages: 110
    This report studies the global Biosimilar Monoclonal Antibodies market status and forecast, categorizes the global Biosimilar Monoclonal Antibodies market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. In 2017, the global Biosimilar Monoclonal Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of ......
  • Global Oncology Biosimilars Market Data Survey Report 2025
    Published: 22-Apr-2018        Price: US 1500 Onwards        Pages: 80
    Summary The global Oncology Biosimilars market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data and export & import Key manufacturers (manufacturing sites, capacity and production, product specifications etc.) Major Application Major Type Key manufacturers are included based on manufacturing sites, capacity......
  • Global and United States Biologics and Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Apr-2018        Price: US 2000 Onwards        Pages: 120
    Summary A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product t......
  • Global and United States Biosimilars Market Research by Company, Type & Application 2013-2025
    Published: 20-Apr-2018        Price: US 2000 Onwards        Pages: 90
    Summary A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Market Segment as follows: By Type - Injection - Tablets - Others By Application - Ankylosing Spondylitis - Tumor - Rheumatoid Arthrtis - Cardiovascular By Company - S......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs